Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mL^b)

Potassium chloride

(Mfr: AGT)(Conc: 0.0249 mg/mL^b)

Remarks:

Persistent particulate formation when blinatumomab is added to potassium chloride; not observed when order of mixing was reversed

Ref:

³⁴⁰⁵,³⁴¹⁷